Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul D van Helden

Showing results (1-10 of 247) with videos related to

Pageof 25
Sort By:
IUBMB Life|July 18, 2002
Molecular epidemiology of TB: challenging dogmas and asking new questionsPaul D van Helden
EMBO Reports|June 6, 2003
The economic divide and tuberculosis. Tuberculosis is not just a medical problem, but also a problem of social inequality and povertyPaul D van Helden
Molecular Carcinogenesis|January 31, 2003
On the nature of genetic changes required for the development of esophageal cancerPieter Uys, Paul D van Helden
BMJ (Clinical Research Ed.)|November 17, 2019
<i>Mycobacterium tuberculosis</i>: concentrate resources on recent infectionsPaul D van Helden, Eileen G Hoal
Comparative Immunology, Microbiology and Infectious Diseases|August 28, 2012
A new TB vaccine: fact or fiction?Paul D van Helden, Eileen G Hoal
Lancet (London, England)|June 6, 2002
HIV-1 and tuberculosis infectionRobin M Warren, Paul D van Helden
The New England Journal of Medicine|June 5, 2009
The global burden of tuberculosis--combating drug resistance in difficult timesPeter R Donald, Paul D van Helden
Journal of Clinical Microbiology|May 8, 2003
Criteria for identification of cross-contamination of cultures of Mycobacterium tuberculosis in routine microbiology laboratoriesNora M Carroll, Madalene Richardson, Paul D van Helden
Science (New York, N.Y.)|October 21, 2006
The "source" of drug-resistant TB outbreaksPaul D van Helden, Tommie Victor, Robin M Warren
The Journal of Infectious Diseases|January 4, 2008
Predicting reinfection in tuberculosisPaul D van Helden, Robin M Warren, Pieter Uys
Pageof 25

Showing results (1-10 of 247) with videos related to

Sort By:
Pageof 25
IUBMB Life|July 18, 2002
Molecular epidemiology of TB: challenging dogmas and asking new questionsPaul D van Helden
EMBO Reports|June 6, 2003
The economic divide and tuberculosis. Tuberculosis is not just a medical problem, but also a problem of social inequality and povertyPaul D van Helden
Molecular Carcinogenesis|January 31, 2003
On the nature of genetic changes required for the development of esophageal cancerPieter Uys, Paul D van Helden
BMJ (Clinical Research Ed.)|November 17, 2019
<i>Mycobacterium tuberculosis</i>: concentrate resources on recent infectionsPaul D van Helden, Eileen G Hoal
Comparative Immunology, Microbiology and Infectious Diseases|August 28, 2012
A new TB vaccine: fact or fiction?Paul D van Helden, Eileen G Hoal
Lancet (London, England)|June 6, 2002
HIV-1 and tuberculosis infectionRobin M Warren, Paul D van Helden
The New England Journal of Medicine|June 5, 2009
The global burden of tuberculosis--combating drug resistance in difficult timesPeter R Donald, Paul D van Helden
Journal of Clinical Microbiology|May 8, 2003
Criteria for identification of cross-contamination of cultures of Mycobacterium tuberculosis in routine microbiology laboratoriesNora M Carroll, Madalene Richardson, Paul D van Helden
Science (New York, N.Y.)|October 21, 2006
The "source" of drug-resistant TB outbreaksPaul D van Helden, Tommie Victor, Robin M Warren
The Journal of Infectious Diseases|January 4, 2008
Predicting reinfection in tuberculosisPaul D van Helden, Robin M Warren, Pieter Uys
Pageof 25